The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies
Open accessAbstract
Purpose of ReviewHypoglycemia is the most common and often treatment-limiting serious adverse effect of diabetes therapy. Despite being potentially preventable, hypoglycemia in type 2 diabetes incurs substantial personal and societal burden. We review the epidemiology of hypoglycemia in type 2 diabetes, discuss key risk factors, and introduce potential prevention strategies.Recent FindingsReported rates of hypoglycemia in type 2 diabetes vary widely as there is marked heterogeneity in how hypoglycemia is defined, measured, and reported. In randomized controlled trials, rates of severe hypoglycemia ranged from 0.7 to 12 per 100 person-years. In observational studies, hospitalizations or emergency department visits for hypoglycemia were experienced by 0.2 (patients treated without insulin or sulfonylurea) to 2.0 (insulin or sulfonylurea users) per 100 person-years. Patient-reported hypoglycemia is much more common. Over the course of 6 months, 1–4% non-insulin users reported need for medical attention for hypoglycemia; 1–17%, need for any assistance; and 46–58%, any hypoglycemia symptoms. Similarly, over a 12-month period, 4–17% of insulin-treated patients reported needing assistance and 37–64% experienced any hypoglycemic symptoms. Hypoglycemia is most common among older patients with multiple or advanced comorbidities, patients with long diabetes duration, or patients with a prior history of hypoglycemia. Insulin and sulfonylurea use, food insecurity, and fasting also increase hypoglycemia risk. Clinical decision support tools may help identify at-risk patients. Prospective trials of efforts to reduce hypoglycemia risk are needed, and there is emerging evidence supporting multidisciplinary interventions including treatment de-intensification, use of diabetes technologies, diabetes self-management, and social support.SummaryHypoglycemia among patients with type 2 diabetes is common. Patient-centered multidisciplinary care may help proactively identify at-risk patients and address the multiplicity of factors contributing to hypoglycemia occurrence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other notable clinical and biological risk factors for hypoglycemia are very young age, older age, multimorbidity, cognitive impairment, chronic kidney disease and kidney failure, CVD, depression, neuropathy, and gastroparesis (94,95,117).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [94]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Individuals at risk for hypoglycemia are those treated with insulin, sulfonylureas, or meglitinides; clinically significant hypoglycemia is rare among individuals taking other diabetes medication classes (94,95).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [94]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Female sex has also been found to be an independent risk factor for hypoglycemia in multiple studies, although the mechanisms of this relationship are unclear and require further research (94).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315 · cited 3×
“…requiring third-party assistance occurred in 1.3% of empaglifozin-treated patients (vs. 1.5% in placebo group; median 3.1 years of observation), [34] 2.4% of liraglutide-treated patients (vs. 3.3% in placebo group; median 3.8 years of observation), [36] 2.1% of saxagliptin-treated patients (vs.…”
InfluentialTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629 · cited 2×
“These trials include EMPA-REG OUTCOME (empagliflozin),[34] CANVAS (canagliflozin),[35] LEADER (liraglutide),[36] SAVOR-TIMI 53 (saxagliptin),[37] TECOS (sitagliptin),[38] EXAMINE (alogliptin),[39] ELIXA (lixisenatide),[40] SUSTAIN-6 (semaglutide),[41] and DEVOTE (insulin degludec).”
InfluentialIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900 · cited 2×
“These trials include EMPA-REG OUTCOME (empagliflozin),[34] CANVAS (canagliflozin),[35] LEADER (liraglutide),[36] SAVOR-TIMI 53 (saxagliptin),[37] TECOS (sitagliptin),[38] EXAMINE (alogliptin),[39] ELIXA (lixisenatide),[40] SUSTAIN-6 (semaglutide),[41] and DEVOTE (insulin degludec).”
InfluentialGlucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Cited by
Sorted by citations
Items 101–200 of 228
Mönnig, E., Spaepen, E., Osumili, B., Mitchell, B. D., Snoek, F. J., Peyrot, M. F., Kern, W., & Holstein, A. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1310-7963 · Cited by 6
Li, Y., Kar, S., Li, C., Liu, M. R., Luan, Z., Yuan, G., Zhong, X., & Mu, Y. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01701-2 · Cited by 5
Zhao, L., Selvaratnam, I., Cunningham, J., Filion, K. B., & Grandi, S. M. (2024) · BMC Pediatrics · doi:10.1186/s12887-024-04963-0 · Cited by 5
Automated insulin delivery systems in elderly patients with brittle type 2 diabetes
Çaklılı, Ö. T., Cetin, F., Özkan, M. K., Şahiner, E., Çakmak, R., Keskin, E., Hacışahinoğulları, H., Goncuoglu, E. S., & Yilmaz, M. T. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111913 · Cited by 5
Naser, A. Y., Qadus, S., Alosaimi, H., AlFayez, A., Huwayshil, H. B., Al Harbi, L. A., Alqhtani, M. S., & Alyamani, N. A. (2025) · Medicine · doi:10.1097/md.0000000000041840 · Cited by 6
Gao, Y., Xu, C., Yang, A., Greco, A., Horodezny, S., Barnet, C., & Gucciardi, E. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.05.006 · Cited by 5
Associations of Colonoscopy and Risk of Hypoglycemia in Patients with Type 2 Diabetes
Yang, H., Liu, D., Zeng, L., Peng, S., & Liu, H. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s401903 · Cited by 5
Metabolic Stress of Red Blood Cells Induces Hemoglobin Glutathionylation
Zaripov, P. I., Kuleshova, I. D., Poluektov, Y. M., Sidorenko, S. V., Кван, О. К., Maksimov, G. V., Mitkevich, V. A., Makarov, A. А., & Petrushanko, I. Y. (2023) · Molecular Biology · doi:10.31857/s0026898423060241 · Cited by 5
Insulin for people with type 2 diabetes mellitus
Vanderpant, N., Ward, E., Farrell, E., & Theodoraki, A. (2024) · BMJ · doi:10.1136/bmj-2023-078015 · Cited by 6
Rodríguez‐Gutiérrez, R., Salcido‐Montenegro, A., González‐González, J. G., & McCoy, R. G. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001906 · Cited by 5
Self-citationHall, M., Walicka, M., Pańczyk, M., & Traczyk, I. (2022) · Nutrients · doi:10.3390/nu14030497 · Cited by 8
Wang, R., Luo, S., Xiao, Z., & Zhou, Z. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3752 · Cited by 4
Income and Severe Hypoglycemia in Type 2 Diabetes
Kim, M., Han, K., Lee, K., Kim, B., Kim, K., Ko, S., Ahn, Y., Kim, S. Y., Lee, S.-H., & Yun, J. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.13293 · Cited by 4
Li, L., Chen, J., Guan, T., Yu, Z. Y., Zhang, J., Ji, R., Li, Z., Lei, M., Gao, F., Li, Y., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112993 · Cited by 4
He, F., Xu, L., Li, Y., & Dong, Y. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i20.7163 · Cited by 4
Dey, A. K., Gokalani, R. A., Kale, M. C., Sankar, P., Saboo, B., Maheshwari, A., Jaggi, S., Jagadeesha, A., Panchal, D., Chawla, M. S., et al. (2024) · Journal of Diabetology · doi:10.4103/jod.jod_121_23 · Cited by 4
Yu, X., Yang, Z., Wang, X., Sun, X., Shen, R., Li, H., & Zhang, M. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02761-3 · Cited by 4
A general view of epidemiology of hypoglycemia in type 1 and type 2 diabetes mellitus
Brož, J., & Urbanová, J. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.050 · Cited by 4
Hundert Jahre – Insulin bleibt aktuell und notwendig
Landgraf, R., & Aberle, J. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1386-0011 · Cited by 4
Hussaini, H. A., Alismael, A., Alquraini, M., Alhabdan, T., Alramadan, H., Alqattan, J., Ali, S. I., Jalal, B. A. A., Almulhim, M., & Sahlawi, M. A. A. (2023) · Cureus · doi:10.7759/cureus.47257 · Cited by 4
Cost-effectiveness of insulin icodec for the treatment of type 2 diabetes in Canada
Garcia, D., Mau, G., Singh, S. R., Spence, M., Jensen, M. S., & Goldenberg, R. (2025) · Journal of Medical Economics · doi:10.1080/13696998.2025.2551449 · Cited by 3
Mirghani, H. O. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4145-z · Cited by 3
Hadid, S. A., Frishman, W. H., & Aronow, W. S. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000940 · Cited by 3
Horii, T., Otsuka, M., & Yasu, T. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003177 · Cited by 3
Hsieh, Y.-S. (2023) · Cureus · doi:10.7759/cureus.41017 · Cited by 3
Glucagon prescribing and prevention of hospitalization for hypoglycemia in a large health system
Herges, J. R., Haag, J. D., Tarpenning, K. A. K., Mara, K. C., & McCoy, R. G. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110832 · Cited by 3
Self-citationGonzález-Saldívar, G., González‐González, J. G., Chow, D. R., Mohamed-Hamsho, J., González-Cortés, J. H., Sánchez‐García, A., & Rodríguez‐Gutiérrez, R. (2023) · International Journal of Clinical Practice · doi:10.1155/2023/9928582 · Cited by 3
Sakyi, S. A., Opoku, S., Senu, E., Korsah, E. E., Effah, A., Baidoo, B. T., Ansah, E. A., Frimpong, E., Naturinda, E., Kodzo, K. E., et al. (2023) · Public Health Challenges · doi:10.1002/puh2.130 · Cited by 3
Orozco‐Beltrán, D., López‐Pineda, A., Quesada, J. A., Artime, E., Díaz‐Cerezo, S., Redondo‐Antón, J., Santos, M. R., Spaepen, E., & Carratalá‐Munuera, C. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.11.007 · Cited by 3
Fan, Y.-P., Lai, T.-H., Lai, J., & Yang, C. (2024) · Geriatric Nursing · doi:10.1016/j.gerinurse.2024.04.024 · Cited by 5
Mechanisms mediating effects of cardiotonic steroids in mammalian blood cells
Poluektov, Y. M., Lopina, O. D., Strelkova, M. A., Kuleshova, I. D., Makarov, A. А., & Petrushanko, I. Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1520927 · Cited by 3
Leto, G., Barchetta, I., Candia, L. D., Magotti, M. G., Cianciullo, M., Manti, R., Negri, C., Cimino, V., Dodesini, A. R., Zerella, F., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01137-4 · Cited by 3
Stuckey, H. L., Desai, U. S., Mitchell, B. D., & Pearson, T. L. (2023) · Diabetic Medicine · doi:10.1111/dme.15084 · Cited by 3
Evaluation of risk factors and correlation in large sample from the perspective of hypoglycemia
Chao, G., Zhu, Y., & Chen, L. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2608 · Cited by 3
Strategies for optimization of hypoglycemia rat models
Zher, L. Y., Kong, E. Q. Z., Raymond, R. E., Jie, Y. Z., & Yap, C. G. (2025) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70045 · Cited by 3
Wang, Y., Jiang, Y., Li, L., Chen, H., Wang, J., Zhang, M., Bai, X., & Wu, S. (2026) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endinu.2025.501759 · Cited by 3
The Cardiovascular Effects of Acute and Chronic Hypoglycemia
Dintakurti, A., Parikh, M. A., Silver, R., Frishman, W. H., & Peterson, S. J. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000001114 · Cited by 2
Yao, J., Zhang, M., Zhang, X., & Zhang, J. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01369-6 · Cited by 2
Krajnc, M., & Tramšek, N. A. K. (2023) · European journal of medical research · doi:10.1186/s40001-023-01081-y · Cited by 2
FAKTOR-FAKTOR YANG MEMENGARUHI HIPOGLIKEMIA PADA PASIEN DIABETES MELITUS TIPE II
Rachmawati, D., Putri, K. W., & Sepdianto, T. C. (2023) · Bali Medika Jurnal · doi:10.36376/bmj.v10i1.316 · Cited by 2
Xu, H., Yu, H., Cheng, Z., Mu, C., Bao, D., Li, X., & Xing, Q. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14135 · Cited by 2
Ralston, J. D., Anderson, M. L., Ng, J., Bashir, A., Ehrlich, K. J., Burns-Hunt, D., Cotton, M., Hansell, L. D., Hsu, C. W., Hunt, H., et al. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107456 · Cited by 2
Tian, L., Liu, K., Li, L., Wu, W., & Zhang, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26137 · Cited by 2
Putallaz, P., Seematter‐Bagnoud, L., Draganski, B., Rouaud, O., Krief, H., & Büla, C. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05025-x · Cited by 2
Gu, W., Tian, Z., Hou, W., Yang, Y., Ma, Y., Song, Y., Wang, H., & Sun, C. (2024) · BMC Public Health · doi:10.1186/s12889-024-20691-7 · Cited by 2
Development and Validation of the Scale of Hypoglycemia Self-Care Behavior in Type 2 Diabetes
Huang, M., Yang, Y., Hsiao, H., & Lee, M. (2025) · Nursing Research · doi:10.1097/nnr.0000000000000808 · Cited by 3
Pfohl, M., Seufert, J., Borck, A., Bramlage, P., & Siegmund, T. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-00998-z · Cited by 2
A novel hypoglycemia alarm framework for type 2 diabetes with high glycemic variability
Wang, X., Yang, Z., Ma, N., Sun, X., Li, H., Zhou, J., & Yu, X. (2023) · International Journal for Numerical Methods in Biomedical Engineering · doi:10.1002/cnm.3799 · Cited by 2
Hypoglycemia: varieties of etiopathogenesis and clinic. Observations from practice
Ляшук, П. М., Lіаshuk, R. P., Marchuk, Y. F., Stankova, N. I., & Kudina, M. B. (2022) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.18.4.2022.1178 · Cited by 1
Sharma, A., Sharma, N., & Chahal, A. (2024) · Journal of Diabetology · doi:10.4103/jod.jod_74_24 · Cited by 1
Machine learning–based prediction model for hypoglycemia during hospitalization in T2DM patients
Niu, W., Liu, C., Wang, S., Zhang, R., Zhang, X., Jia, H., Huang, J., Peng, H., Jiang, H., Jia, Z., et al. (2025) · Interdisciplinary Nursing Research · doi:10.1097/nr9.0000000000000087 · Cited by 1
Timple, V. S., SOLIMAN, E. D. P., Frulla, G., Kawar, L. N., & Nguyen, A. (2025) · AJN American Journal of Nursing · doi:10.1097/ajn.0000000000000082 · Cited by 1
Hypoglycemia-Induced Irreversible Brain Injury: A Case Report
Bisht, A., Erdem, S., Gupta, R., & Makki, H. (2025) · Cureus · doi:10.7759/cureus.86912 · Cited by 2
Potential Drug Dose‐Specific Adverse Three‐Drug Combinations: A US Insurance Claims Data‐Based Study
Shi, Y., Sun, A., Chiang, C., Yang, Y., Hunold, K. M., Xu, J., Russo, M., Caterino, J. M., Eadon, M. T., Li, L., et al. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70199 · Cited by 1
Chen, L., Wang, L., Fu, A., Yang, J., Lan, Y., Wang, Z., Wang, D., & Cheng, S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70297 · Cited by 1
Liu, Y., Guo, C., Li, X., Li, S., Huang, J., Zhao, L., Zhu, Y., Liu, X., Wang, B., Lin, R., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1685969 · Cited by 2
Almehthel, M. S., Al-Saeed, A., Alsabaan, F., Almalki, F., ZARIF, H. A., Al-Zubaidi, L., Al‐Sofiani, M. E., Abdulaal, O., Argan, R. A., Sifri, S. A., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1738398 · Cited by 2
Wan, H., Wen, B., Wang, Y., Wang, J., Zhang, Y., Ning, T., Duan, B., Li, Y., Feng, W., Zhang, X., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01112-z · Cited by 1
Nnakenyi, I. D., Arum, E. J., Young, E. E., Anyim, O. B., Nnakenyi, E. F., & Okoro, N. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221104467 · Cited by 1
Prevalence of Hypoglycemia in Patients of Type 2 Diabetes Mellitus
Javed, S. M., Khan, N. N., Babur, W., Memon, F. A., Arshad, A., & Huma, Z. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs221651108 · Cited by 1
Integrated hydrogel sensor-actuator for glucose sensitivity and drug elution
Velraj, A., & Bates, J. S. (2022) · MRS Advances · doi:10.1557/s43580-022-00331-1 · Cited by 1
Heller, S. R., Battelino, T., Bailey, T. S., Pieber, T. R., Hövelmann, U., Plum‐Mörschel, L., Melgaard, A. E., Aronson, R., DiMeglio, L. A., Johansen, T., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14987 · Cited by 7
Singh, S. A., Singh, A. N., Patel, S., & Sangwan, S. (2023) · Saudi Journal of Medicine · doi:10.36348/sjm.2023.v08i02.004 · Cited by 1
Identifying and Assessing Self-Management Behaviours
Henriques, H. R., Camolas, J., Pimenta, N. M., & Mendes, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-20010-6_3 · Cited by 1
FREQUENCY OF HYPOGLYCEMIA IN NEWBORN WITH BIRTH ASPHYXIA
Ahmad, Z., KHAN, I., & SHEHZAD, A. (2024) · Biological and Clinical Sciences Research Journal · doi:10.54112/bcsrj.v2024i1.677 · Cited by 1
Magbol, M., Alaziz, W. M. A., Osman, A. M. S., Allah, N. A. K., Alkhowad, N. O., Izzoddeen, A., & Alsugud, S. A. A. (2024) · Journal of Family Medicine and Health Care · doi:10.11648/j.jfmhc.20241001.12 · Cited by 1
Krishnamoorthy, S., Pandurangan, V., Varadan, S., Gopalan, S., & Singh, S. (2024) · Scripta Medica · doi:10.5937/scriptamed55-50079 · Cited by 1
Yanaizumi, R., Nagamine, Y., Harada, S., & Goto, T. (2024) · Palliative Medicine Reports · doi:10.1089/pmr.2024.0008 · Cited by 1
System engineering approach of the home self-management of type 2 diabetes: a work in progress
Marcilly, R., Forrierre, J., Thébault, J., Bayen, S., & Grimes, T. (2024) · European Conference on Cognitive Ergonomics · doi:10.1145/3673805.3673840 · Cited by 1
Huang, M., Hsiao, H., Yang, Y., Liang, H., & Chen, C. (2025) · Applied Nursing Research · doi:10.1016/j.apnr.2025.151916 · Cited by 1
Lin, Y. K., Black, J. E., Harris, S. B., Ryan, B. L., Zou, G., & Ratzki‐Leewing, A. A. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112230 · Cited by 1
Anderson, J. E., Urquhart, S., Spollett, G. R., & Dandona, P. (2020) · Clinical Diabetes · doi:10.2337/cd20-0035 · Cited by 1
Rosenstock, J., Blonde, L., Aroda, V. R., Frías, J. P., Souhami, E., Ji, C. F., Niemoeller, E., & Prato, S. D. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14345 · Cited by 1
COVID-19 lockdown and hypoglycemia among patients with diabetes fasting the month of Ramadan 2020
Ghareeb, Z., Saffar, Z., Al-Ghareeb, G., Almaalu, G., & Alnaji, A. (2021) · Journal of Diabetes and Endocrine Practice · doi:10.4103/jdep.jdep_1_21 · Cited by 1
Research Progress of Hypoglycemia
陈, 小. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12101329 · Cited by 1
Harris, S. B., Mohammedi, K., Bertolini, M., White, J. C., Walker, V., Zhou, F. L., Anderson, J. E., & Seufert, J. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14973 · Cited by 1
Ko, S. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2025.2403 · Cited by 1
Risk of hypoglycemia in hospitalized patients with diabetes mellitus
Brož, J., & Nyčová, A. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.12.012
Sugiyama, K., Meguro, S., Saisho, Y., Irie, J., Tanaka, M., & Itoh, H. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e01257
Gorgzadeh, N., Taghizadeh‐Ghehi, M., & Kohneloo, A. J. (2020) · Journal of Research in Pharmacy Practice · doi:10.4103/jrpp.jrpp_19_111
Ó, D. D., Andrade, R., Ribeiro, R. T., Serrabulho, L., & Raposo, J. F. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3906005
Evolution in Overcoming Barriers in Management of Diabetes: Hypoglycemia
Banzal, S., Banzal, S., & Kabadi, U. M. (2021) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2021.115020 · Cited by 1
農協におけるBCP(事業継続計画)の策定と実践(第8回)JAらしいBCPの実践とは
Tooru, K. (2013) · 農業協同組合経営実務
Hypoglycemia Detection in Diabetes
Richardson, J. M., & Shaginian, R. M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103137
Diabetologische Notfälle im Krankenhaus
Seibold, J., Ramshorn-Zimmer, A., Ebert, T., & Tönjes, A. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00875-8
Abu-Odeh, A., Alnatour, D., & Fino, L. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105061
Huang, B., Jiang, Q., Wu, T., Shen, Q., Wang, W., Wang, S., Huang, Y., Wang, S., Huang, P., Lin, M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2105445/v1
Chernikova, N. A., Kamynina, L. L., As, A., & Sychov, D. A. (2022) · Diabetes Mellitus · doi:10.14341/dm12902
Proportion of Type 2 Diabetes Mellitus Patients with Hypoglycemia
Ali, B., Sarwar, M. U., Hameed, S., Bashir, J., Hussain, S. I., & Ashraf, A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22169541
Future perspectives for diabetic retinopathy management
Li, W., & Zhang, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-93064-2.00006-8
Han, X., Xue, P., Yang, J., Wang, L., Li, Z., Wei, M., & Ma, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-2750981/v1
Minimizing Hypoglycemia with Insulin Therapy
Priya, G., & Grewal, E. (2022) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_9_22
Aspectos Clave de la Medicina Crítica y la Gestión de Emergencias
Intriago, G. G. G., Urgiles, D. S. C., Molina, N. A. Y., Barba, D. F. D., Carvajal, M. G. M., Reyes, M. D. C. A., & Fuentes, J. N. I. (2023) · Juan Cuevas eBooks · doi:10.56470/978-9942-650-08-5
Henao, D. C., Medina, A. M. G., García-Cajiao, A., Robledo, S., Mejía, G., Padilla, S. N. C., Kerguelen, A., Rubio, C., Rondón, M., & Múñoz, Ó. (2023) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.10.3.796
Metabolic Stress of Red Blood Cells Induces Hemoglobin Glutathionylation
Zaripov, P. I., Kuleshova, I. D., Poluektov, Y. M., Sidorenko, S. V., Кван, О. К., Maksimov, G. V., Mitkevich, V. A., Makarov, A. А., & Petrushanko, I. Y. (2023) · Molecular Biology · doi:10.1134/s0026893323060225
Elolemy, N., Ahmed, S. M. R., Hafez, Y. M., & Elbana, H. A. (2023) · Tanta Scientific Nursing Journal · doi:10.21608/tsnj.2023.328655
Profile of Hypoglycemia Incidence in Type 2 Diabetes Mellitus Patients with Sulfonylurea Therapy
Adiyatma, A. E., Prajitno, J. H., Purwanto, B., & Susanto, H. (2023) · International Journal of Research Publications · doi:10.47119/ijrp10013811220235719
L’interprofessionalità medico-infermieristica in Medicina Interna
Attardo, T. M., Tesei, L., Manfellotto, D., & Dentali, F. (2024) · Italian Journal of Medicine · doi:10.4081/itjm.q.2024.2
Sulfonilurea Menyebabkan Hipoglikemia Berat pada Pasien Lanjut Usia Dengan DM Tipe 2: Laporan Kasus
Mardaningrat, G. A. M., & Pramarta, D. Y. (2024) · Unram Medical Journal · doi:10.29303/jk.v13i1.4142
Li, L., Liu, S., & Yang, P. C. (2024) · Research Square · doi:10.21203/rs.3.rs-4610003/v1
Metadata
- Authors
- Silbert, R., Salcido-Montenegro, A., Rodriguez-Gutierrez, R., Katabi, A., & McCoy, R. G.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- McCoy, Rozalina G.
- Venue
- Current Diabetes Reports
- Published
- 2018-06-21
- Volume
- 18
- Issue
- 8
- Pages
- 53-53
- ISSN
- 1534-4827 (ISSN-L)
- 1539-0829
- PMC
- PMC6117835
- OpenAlex
- W2809031508
- Semantic Scholar
- d6d2b9f681259ecdf86d479f18c51145da848f3e
- Cited by
- 229
- References
- 126
- Citations by year
- 2026: 15 · 2025: 34 · 2024: 42 · 2023: 47 · 2022: 36 · 2021: 24 · 2020: 15 · 2019: 14 · 2018: 1
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Diabetes Reports (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Mayo Clinic
- National Institute of Diabetes and Digestive and Kidney Diseases (K23DK114497)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- hypoglycemia, type 2 diabetes, hypoglycemia risk factors, hypoglycemia prevention, insulin therapy, sulfonylureas, food insecurity, fasting, diabetes duration, comorbidities, clinical decision support, treatment deintensification, diabetes self-management, diabetes technology, multidisciplinary care
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 2, Humans, Hypoglycemia, Risk Factors, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
